Liquid cancer test offers hope for alternative to painful biopsies
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Chicago
A BLOOD test to detect cancer mutations produced results that generally agree with those of an invasive tumour biopsy, researchers reported, heralding a time when diagnosing cancer and monitoring its progression may become less painful and risky.
The blood tests, known as liquid biopsies, represent one of the hottest trends in oncology. They take advantage of the fact that DNA fragments from tumours can be found in tiny amounts in the blood of patients with cancer.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
